Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Open House Biologics Discount Agreements 2025-01 - Infliximab

Techniker Krankenkasse Germany has Released a tender for Open House Biologics Discount Agreements 2025-01 - Infliximab in Pharmaceuticals. The tender was released on Feb 13, 2025.

Country - Germany

Summary - Open House Biologics Discount Agreements 2025-01 - Infliximab

Deadline - Mar 31, 2027

GT reference number - 103282983

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 103282983

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The participating health insurance companies aim to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 of the Social Security Code (SGB V) for the active ingredient inflixi mab (see below for the division into two lots). The contract is concluded as part of the open house biologics procedure of the participating health insurance companies:local title:: Open-House-Biologika-Rabattverträge 2025-01 - Infliximablocal description: : Die beteiligten Kassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Infliximab (zur Unterteilung in zwei

Gt Ref Id - 103282983

Deadline - Mar 31, 2027

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database